IOVA logo

Iovance Biotherapeutics (IOVA) Net Income

Annual Net Income

-$372.18 M
+$71.86 M+16.18%

December 31, 2024

Summary

Performance

1-Year Change

+16.18%

3-Year Change

-8.74%

5-Year Change

-88.39%

15-Year Change

-304.26%

IOVA Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.37%
IOVA annual net profit is higher than 4.37% of companies in Healthcare sector

High & Low

All-time High

-$15.80 K

3-Year Low

-$444.04 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
IOVA previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
IOVA next annual earnings announcement has not yet been scheduled

OtherIOVAprofitabilitymetrics:

Annual Net Margin

-226.84%
IOVA annual net profit margin is -226.84%

Annual Revenue

$164.07 M
IOVA annual revenue is $164.07 million

Annual Gross Profit

$40.08 M
IOVA annual gross profit is $40.08 million

Annual EPS

-$1.28
IOVA annual earnings per share is -$1.28

Quarterly Net Income

-$78.56 M
+$4.98 M+5.96%

December 31, 2024

Summary

Performance

3-Month Change

+5.96%

1-Year Change

+30.46%

3-Year Change

+20.93%

5-Year Change

+20.93%

IOVA Quarterly Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

5.88%
IOVA quarterly net profit is higher than 5.88% of companies in Healthcare sector

High & Low

All-time High

$3.47 M
IOVA quarterly net profit is currently -2366.43% below its historical high of $3.47 million

3-Year Low

-$116.38 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
IOVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
IOVA next earnings announcement has not yet been scheduled

OtherIOVAprofitabilitymetrics:

Quarterly Net Margin

-
IOVA quarterly net profit margin value is unknown

Quarterly Revenue

$73.69 M
IOVA quarterly revenue is $73.69 million

Quarterly Gross Profit

$28.15 M
IOVA quarterly gross profit is $28.15 million

Quarterly EPS

-$0.26
IOVA quarterly earnings per share is -$0.26

TTM Net Income

-$372.18 M
+$37.82 M+9.22%

December 31, 2024

Summary

Performance

3-Month Change

+9.22%

1-Year Change

+17.23%

3-Year Change

+1.12%

5-Year Change

+1.12%

IOVA TTM Net Income Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

4.51%
IOVA TTM net profit is higher than 4.51% of companies in Healthcare sector

High & Low

All-time High

$1.42 M
IOVA TTM net profit is currently <-9900.00% below its historical high of $1.42 million

3-Year Low

-$449.64 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
IOVA previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

N/A
IOVA next earnings announcement has not yet been scheduled

OtherIOVAprofitabilitymetrics:

Annual Net Margin

-226.84%
IOVA annual net profit margin is -226.84%

TTM Revenue

$164.07 M
IOVA TTM revenue is $164.07 million

TTM Gross Profit

$40.07 M
IOVA TTM gross profit is $40.07 million

TTM EPS

-$1.30
IOVA TTM earnings per share is -$1.30

Net Income Formula

Net Income = Revenue − COGS − Operating Expenses − Interest − Taxes − Other Expenses

Annual Net Income

-$372.18 M
IOVA annual net profit is -$372.18 million

Annual Revenue

$164.07 M
IOVA annual revenue is $164.07 million

Annual Cost Of Goods Sold

$124.00 M
IOVA annual cost of goods sold is $124.00 million

Annual Operating Expenses

$435.35 M
IOVA annual total operating expenses is $435.35 million

Annual Interest Expense

-
IOVA annual interest expense value is unknown

Annual Income Tax

-$2.83 M
IOVA annual income tax is -$2.83 million

IOVA Net Income Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+16.2%+30.5%+17.2%
3 y3 years-8.7%+20.9%+1.1%
5 y5 years-88.4%+20.9%+1.1%

IOVA Net Income Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.7%+16.2%at high+32.5%-8.7%+17.2%
5 y5-year-88.4%+16.2%-34.1%+32.5%-88.4%+17.2%
alltimeall time<-9999.0%+16.2%-2366.4%+32.5%<-9999.0%+17.2%

Iovance Biotherapeutics Net Income History

DateAnnualQuarterlyTTM
Dec 2024
-$372.18 M(-16.2%)
-$78.56 M(-6.0%)
-$372.18 M(-9.2%)
Sep 2024
-
-$83.54 M(-14.0%)
-$410.00 M(-6.9%)
Jun 2024
-
-$97.10 M(-14.1%)
-$440.22 M(-2.1%)
Mar 2024
-
-$112.98 M(-2.9%)
-$449.64 M(+1.3%)
Dec 2023
-$444.04 M(+12.2%)
-$116.38 M(+2.3%)
-$444.04 M(+2.6%)
Sep 2023
-
-$113.76 M(+6.8%)
-$432.98 M(+3.4%)
Jun 2023
-
-$106.53 M(-0.8%)
-$418.83 M(+1.7%)
Mar 2023
-
-$107.37 M(+1.9%)
-$411.66 M(+4.0%)
Dec 2022
-$395.89 M(+15.7%)
-$105.32 M(+5.7%)
-$395.89 M(+1.5%)
Sep 2022
-
-$99.62 M(+0.3%)
-$389.90 M(+3.6%)
Jun 2022
-
-$99.35 M(+8.5%)
-$376.41 M(+5.0%)
Mar 2022
-
-$91.61 M(-7.8%)
-$358.41 M(+4.7%)
Dec 2021
-$342.25 M(+31.8%)
-$99.33 M(+15.3%)
-$342.25 M(+9.9%)
Sep 2021
-
-$86.12 M(+5.9%)
-$311.32 M(+9.7%)
Jun 2021
-
-$81.35 M(+7.8%)
-$283.77 M(+6.9%)
Mar 2021
-
-$75.45 M(+10.3%)
-$265.44 M(+2.3%)
Dec 2020
-$259.58 M(+31.4%)
-$68.40 M(+16.8%)
-$259.58 M(+1.9%)
Sep 2020
-
-$58.57 M(-7.1%)
-$254.75 M(+3.7%)
Jun 2020
-
-$63.02 M(-9.5%)
-$245.67 M(+6.7%)
Mar 2020
-
-$69.59 M(+9.5%)
-$230.20 M(+16.5%)
Dec 2019
-$197.56 M(+59.9%)
-$63.57 M(+28.5%)
-$197.56 M(+18.6%)
Sep 2019
-
-$49.49 M(+4.1%)
-$166.56 M(+10.4%)
Jun 2019
-
-$47.55 M(+28.7%)
-$150.91 M(+12.6%)
Mar 2019
-
-$36.95 M(+13.4%)
-$134.01 M(+8.4%)
Dec 2018
-$123.58 M(+34.2%)
-$32.58 M(-3.7%)
-$123.58 M(+5.8%)
Sep 2018
-
-$33.83 M(+10.3%)
-$116.86 M(+11.1%)
Jun 2018
-
-$30.66 M(+15.6%)
-$105.18 M(+7.4%)
Mar 2018
-
-$26.52 M(+2.6%)
-$97.89 M(+6.3%)
Dec 2017
-$92.06 M(+74.1%)
-$25.85 M(+16.7%)
-$92.06 M(+12.4%)
Sep 2017
-
-$22.15 M(-5.3%)
-$81.90 M(+4.3%)
Jun 2017
-
-$23.38 M(+13.0%)
-$78.51 M(+17.7%)
Mar 2017
-
-$20.68 M(+31.8%)
-$66.69 M(+26.1%)
Dec 2016
-$52.89 M
-$15.69 M(-16.4%)
-$52.89 M(+16.1%)
Sep 2016
-
-$18.76 M(+62.2%)
-$45.56 M(+32.3%)
DateAnnualQuarterlyTTM
Jun 2016
-
-$11.56 M(+68.0%)
-$34.44 M(+17.8%)
Mar 2016
-
-$6.88 M(-17.7%)
-$29.25 M(+5.7%)
Dec 2015
-$27.66 M(+129.8%)
-$8.36 M(+9.5%)
-$27.66 M(+14.5%)
Sep 2015
-
-$7.63 M(+19.9%)
-$24.17 M(+25.0%)
Jun 2015
-
-$6.37 M(+20.2%)
-$19.33 M(+28.2%)
Mar 2015
-
-$5.30 M(+8.9%)
-$15.07 M(+25.2%)
Dec 2014
-$12.04 M(-52.6%)
-$4.87 M(+73.9%)
-$12.03 M(-35.5%)
Sep 2014
-
-$2.80 M(+32.6%)
-$18.66 M(-26.2%)
Jun 2014
-
-$2.11 M(-6.6%)
-$25.28 M(-5.0%)
Mar 2014
-
-$2.26 M(-80.3%)
-$26.60 M(+4.8%)
Dec 2013
-$25.38 M(+667.4%)
-$11.50 M(+22.2%)
-$25.38 M(+143.6%)
Sep 2013
-
-$9.41 M(+174.4%)
-$10.42 M(+518.9%)
Jun 2013
-
-$3.43 M(+227.7%)
-$1.68 M(-218.7%)
Mar 2013
-
-$1.05 M(-130.2%)
$1.42 M(-142.9%)
Dec 2012
-$3.31 M(-87.1%)
$3.47 M(-614.3%)
-$3.31 M(-78.1%)
Sep 2012
-
-$673.90 K(+105.9%)
-$15.13 M(-25.4%)
Jun 2012
-
-$327.30 K(-94.3%)
-$20.27 M(-34.4%)
Mar 2012
-
-$5.77 M(-30.9%)
-$30.90 M(+20.3%)
Dec 2011
-$25.69 M(+1497.9%)
-$8.35 M(+43.5%)
-$25.69 M(+42.1%)
Sep 2011
-
-$5.82 M(-46.9%)
-$18.08 M(+39.3%)
Jun 2011
-
-$10.96 M(+1842.2%)
-$12.98 M(+516.7%)
Mar 2011
-
-$564.30 K(-23.9%)
-$2.10 M(+30.9%)
Dec 2010
-$1.61 M(>+9900.0%)
-$741.90 K(+3.9%)
-$1.61 M(+85.2%)
Sep 2010
-
-$713.80 K(+743.7%)
-$868.40 K(+449.3%)
Jun 2010
-
-$84.60 K(+25.0%)
-$158.10 K(+105.9%)
Mar 2010
-
-$67.70 K(+2843.5%)
-$76.80 K(+389.2%)
Dec 2009
-$15.80 K(-72.3%)
-$2300.00(-34.3%)
-$15.70 K(-43.3%)
Sep 2009
-
-$3500.00(+6.1%)
-$27.70 K(+3.7%)
Jun 2009
-
-$3300.00(-50.0%)
-$26.70 K(-30.5%)
Mar 2009
-
-$6600.00(-53.8%)
-$38.40 K(-32.7%)
Dec 2008
-$57.10 K
-$14.30 K(+472.0%)
-$57.10 K(+33.4%)
Sep 2008
-
-$2500.00(-83.3%)
-$42.80 K(+6.2%)
Jun 2008
-
-$15.00 K(-40.7%)
-$40.30 K(+59.3%)
Mar 2008
-
-$25.30 K
-$25.30 K

FAQ

  • What is Iovance Biotherapeutics annual net profit?
  • What is the all time high annual net income for Iovance Biotherapeutics?
  • What is Iovance Biotherapeutics annual net income year-on-year change?
  • What is Iovance Biotherapeutics quarterly net profit?
  • What is the all time high quarterly net income for Iovance Biotherapeutics?
  • What is Iovance Biotherapeutics quarterly net income year-on-year change?
  • What is Iovance Biotherapeutics TTM net profit?
  • What is the all time high TTM net income for Iovance Biotherapeutics?
  • What is Iovance Biotherapeutics TTM net income year-on-year change?

What is Iovance Biotherapeutics annual net profit?

The current annual net income of IOVA is -$372.18 M

What is the all time high annual net income for Iovance Biotherapeutics?

Iovance Biotherapeutics all-time high annual net profit is -$15.80 K

What is Iovance Biotherapeutics annual net income year-on-year change?

Over the past year, IOVA annual net profit has changed by +$71.86 M (+16.18%)

What is Iovance Biotherapeutics quarterly net profit?

The current quarterly net income of IOVA is -$78.56 M

What is the all time high quarterly net income for Iovance Biotherapeutics?

Iovance Biotherapeutics all-time high quarterly net profit is $3.47 M

What is Iovance Biotherapeutics quarterly net income year-on-year change?

Over the past year, IOVA quarterly net profit has changed by +$34.42 M (+30.46%)

What is Iovance Biotherapeutics TTM net profit?

The current TTM net income of IOVA is -$372.18 M

What is the all time high TTM net income for Iovance Biotherapeutics?

Iovance Biotherapeutics all-time high TTM net profit is $1.42 M

What is Iovance Biotherapeutics TTM net income year-on-year change?

Over the past year, IOVA TTM net profit has changed by +$77.47 M (+17.23%)